Karyopharm Therapeutics Inc (KPTI)

Dec 21, 2024

Fmr LLC Buys 76,510 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World

Dec 21, 2024

Dec 18, 2024

KPTI stock touches 52-week low at $0.65 amid market challenges By Investing.com - Investing.com South Africa

Dec 18, 2024

Dec 18, 2024

KPTI stock touches 52-week low at $0.65 amid market challenges - Investing.com Canada

Dec 18, 2024

Dec 16, 2024

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Eastern Progress Online

Dec 16, 2024

Dec 16, 2024

Karyopharm Therapeutics Inc.'s SWOT analysis: oncology firm's stock faces pivotal trials - Investing.com

Dec 16, 2024

Dec 12, 2024

Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024 - The Eastern Progress Online

Dec 12, 2024

Dec 10, 2024

Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications - Kilgore News Herald

Dec 10, 2024

Dec 09, 2024

Karyopharm Appoints Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications - citybiz

Dec 09, 2024

Dec 06, 2024

Karyopharm CEO Richard Paulson sells $2,932 in stock By Investing.com - Investing.com Nigeria

Dec 06, 2024

Dec 05, 2024

Karyopharm CEO Richard Paulson sells $2,932 in stock - Investing.com

Dec 05, 2024

Dec 04, 2024

Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update comes in li - Defense World

Dec 04, 2024

Dec 04, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Update - Defense World

Dec 04, 2024

Dec 03, 2024

Karyopharm Engages with FDA on Cancer Trial Plans - TipRanks

Dec 03, 2024

Dec 03, 2024

Karyopharm Therapeutics Provides Endometrial Cancer Program Update - Investor Relations | Karyopharm Therapeutics

Dec 03, 2024

Dec 03, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Sees Large Growth in Short Interest - MarketBeat

Dec 03, 2024

Dec 02, 2024

Karyopharm reports inducement grants under Nasdaq listing rule - TipRanks

Dec 02, 2024

Dec 02, 2024

Karyopharm Therapeutics Awards 4,800 RSUs to New Employees in Retention Plan - StockTitan

Dec 02, 2024

Nov 30, 2024

Karyopharm Therapeutics (STU:25K) Operating Cash Flow per S - GuruFocus.com

Nov 30, 2024

Nov 26, 2024

KPTI (Karyopharm Therapeutics) Market Cap : $109.8 Mil (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Rating Lowered by StockNews.com - Defense World

Nov 26, 2024

Nov 25, 2024

Karyopharm Therapeutics' SWOT analysis: oncology stock faces pivotal trials - Investing.com

Nov 25, 2024

Nov 25, 2024

Glioblastoma Multiforme Treatment Market Size to Reach USD 5.68 Bn by 2033 - GlobeNewswire Inc.

Nov 25, 2024

Nov 25, 2024

Karyopharm Therapeutics to Present at Piper Sandler Healthcare Conference | KPTI Stock News - StockTitan

Nov 25, 2024

Nov 21, 2024

Karyopharm appoints new chief accounting officer By Investing.com - Investing.com Canada

Nov 21, 2024

Nov 21, 2024

Karyopharm gains after changes to late-stage trial - MSN

Nov 21, 2024

Nov 21, 2024

Karyopharm appoints new chief accounting officer - Investing.com India

Nov 21, 2024

Nov 21, 2024

Karyopharm Therapeutics Appoints Kristin Abate Chief Accounting Officer - citybiz

Nov 21, 2024

Nov 20, 2024

Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer - Citizentribune

Nov 20, 2024

Nov 20, 2024

Karyopharm Therapeutics Appoints New Chief Accounting Officer - TipRanks

Nov 20, 2024

Nov 20, 2024

Karyopharm appoints Kristin Abate as Chief Accounting Officer - TipRanks

Nov 20, 2024

Nov 18, 2024

Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition - PR Newswire

Nov 18, 2024

Nov 15, 2024

Avidity Partners Management LP's Strategic Acquisition of Karyop - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress By Investing.com - Investing.com Nigeria

Nov 14, 2024

Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress - Investing.com India

Nov 14, 2024

Nov 14, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Rating Upgraded by StockNews.com - MarketBeat

Nov 14, 2024

Nov 14, 2024

GSA Capital Partners LLP Purchases 792,283 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat

Nov 14, 2024